Japanese vendor Hitachi Medical of Tokyo has formed a new nuclearmedicine division to handle direct sales in North America of itsgamma cameras. The move culminates Hitachi's comeback in the modality,which began when Summit Nuclear stopped marketing the
Japanese vendor Hitachi Medical of Tokyo has formed a new nuclearmedicine division to handle direct sales in North America of itsgamma cameras. The move culminates Hitachi's comeback in the modality,which began when Summit Nuclear stopped marketing the Hitachiproducts following the merger of Summit and Sopha Medical (SCAN10/11/95).
Hitachi's Nuclear Medicine Products Division will be based inTwinsburg, OH, and will be a subsidiary of Hitachi Medical Corporationof America, which is based in Tarrytown, NY. Former Summit executiveGary Enos is general manager of the division.
At last month's Radiological Society of North America meeting,Hitachi displayed SpectraDigital V250 DSP, the company's variable-angledual-head gamma camera. The company also had panels on 511-keVcollimation and a work-in-progress Coincidence Detection Reconstruction(CDR) technique.
Hitachi is also developing a new nuclear medicine workstation,SpectraDigital 300SS, which is based on a Hewlett-Packard platformwith applications software developed in cooperation with MedasysDigital Systems. The computer is expected to be available earlythis year.
Can AI Enhance CT Detection of Incidental Extrapulmonary Abnormalities and Prediction of Mortality?
September 18th 2024Emphasizing multi-structure segmentation and feature extraction from chest CT scans, an emerging AI model demonstrated an approximately 70 percent AUC for predicting significant incidental extrapulmonary findings as well as two-year and 10-year all-cause mortality.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Assesses Lung CT-Based AI Models for Predicting Interstitial Lung Abnormality
September 6th 2024A machine-learning-based model demonstrated an 87 percent area under the curve and a 90 percent specificity rate for predicting interstitial lung abnormality on CT scans, according to new research.